Canadian researchers recently discovered there is an increased risk of heart attack and other heart related problems when using Merck and Co.’s pain reliever Vioxx during the first two weeks. Previously, other studies emphasized the increased risks of heart related problems stemming from Vioxx after taking the drug for 18 months or more. These findings could have a huge impact on the over 11,000 lawsuits now pending against the drug manufacture.
According to theglobeandmail.com
“The results emphasize first that we can’t necessarily assume that the risk takes 18 months or more to appear and that there’s a need for early monitoring of people who take these medications,” said Linda Levesque, a professor of community health and epidemiology at Queen’s University in Kingston, Ont.
“There are multiple lawsuits being argued in the States and there seems to be a line being drawn between those occurring earlier than 18 months as being non-viable and those occurring after.”
For more information on this new Vioxx study click here….
@thumbnail.jpg "M. Brandon Smith")
A partner with Childers, Schlueter & Smith, LLC,, Brandon Smith has devoted his practice to pharmaceutical litigation, mass torts, products liability and serious personal injury. A frequent guest speaker at legal seminars all over the country—Brandon is focused on helping injured victims nationwide, however possible. Named a SuperLawyer again in 2019, he has also been called out as one of 10 Best Attorneys For Georgia by the American Institute Of Personal Injury Attorneys and a Top 100 Lawyer in Georgia by the National Trial Lawyers in 2019.
Comments for this article are closed.